- £7.36m
- £7.14m
- $43.76m
- 28
- 72
- 40
- 41
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 53.7 | 53.2 | 46.1 | 53.9 | 43.8 |
Cost of Revenue | |||||
Gross Profit | 41.7 | 39.3 | 36.5 | 44.1 | 33.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 46.1 | 65 | 44.2 | 70.1 | 69 |
Operating Profit | 7.6 | -11.8 | 1.87 | -16.2 | -25.2 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 7.13 | -12.4 | 1.43 | -17.1 | -30.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.112 | -18.2 | -3.83 | -24 | -36.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 0.112 | -18.2 | -2.06 | -24 | -35.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.112 | -18.2 | -2.06 | -24 | -35.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.012 | -0.062 | -0.019 | -0.086 | -0.156 |